Mitochondria-Targeting Small Molecules Effectively Prevent Cardiotoxicity Induced by Doxorubicin

Doxorubicin (Dox) is a chemotherapeutic agent widely used for the treatment of numerous cancers. However, the clinical use of Dox is limited by its unwanted cardiotoxicity. Mitochondrial dysfunction has been associated with Dox-induced cardiotoxicity. To mitigate Dox-related cardiotoxicity, consider...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Wei, Deng, Hongkuan, Zhang, Jianyong, Zhang, Ying, Zhang, Xiufang, Cui, Guozhen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2018
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099719/
https://www.ncbi.nlm.nih.gov/pubmed/29921817
http://dx.doi.org/10.3390/molecules23061486

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6099719/
https://www.ncbi.nlm.nih.gov/pubmed/29921817
http://dx.doi.org/10.3390/molecules23061486

Ejemplares similares